| Nome |
# |
|
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells, file e0feeaa7-9dd6-44d2-e053-6605fe0a8db0
|
190
|
|
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea, file e0feeaa6-dea2-44d2-e053-6605fe0a8db0
|
174
|
|
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output, file e0feeaa8-526e-44d2-e053-6605fe0a8db0
|
148
|
|
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells, file e0feeaa7-d9ff-44d2-e053-6605fe0a8db0
|
144
|
|
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents, file e0feeaa6-2197-44d2-e053-6605fe0a8db0
|
143
|
|
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties, file e0feeaa7-e76c-44d2-e053-6605fe0a8db0
|
136
|
|
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1, file e0feeaa7-be29-44d2-e053-6605fe0a8db0
|
122
|
|
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing, file e0feeaa8-8a4c-44d2-e053-6605fe0a8db0
|
117
|
|
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance, file 5c485f25-7727-4c0d-9baa-6cf2af54b0af
|
105
|
|
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells, file e0feeaa9-3d53-44d2-e053-6605fe0a8db0
|
72
|
|
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels, file e0feeaa9-4273-44d2-e053-6605fe0a8db0
|
72
|
|
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells, file e0feeaa6-d8d9-44d2-e053-6605fe0a8db0
|
70
|
|
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data, file e0feeaa9-b617-44d2-e053-6605fe0a8db0
|
65
|
|
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity, file e0feeaa5-6b36-44d2-e053-6605fe0a8db0
|
59
|
|
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response, file e0feeaa5-c1e3-44d2-e053-6605fe0a8db0
|
58
|
|
Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells, file e0feeaa9-7afd-44d2-e053-6605fe0a8db0
|
57
|
|
Repurposing of drugs for triple negative breast cancer: an overview, file e0feeaa9-4d09-44d2-e053-6605fe0a8db0
|
54
|
|
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer, file e0feeaa9-d1b5-44d2-e053-6605fe0a8db0
|
52
|
|
The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo., file e0feeaa4-c77b-44d2-e053-6605fe0a8db0
|
46
|
|
New Insights Into Blood-Brain Barrier Maintenance: The Homeostatic Role of β-Amyloid Precursor Protein in Cerebral Vasculature, file e0feeaa9-24e4-44d2-e053-6605fe0a8db0
|
37
|
|
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review, file e0feeaa8-9d47-44d2-e053-6605fe0a8db0
|
28
|
|
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation, file e0feeaab-d73a-44d2-e053-6605fe0a8db0
|
28
|
|
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade, file 85c86020-3b4b-4f00-b393-0337e790dcd9
|
21
|
|
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells, file e0feeaab-92f5-44d2-e053-6605fe0a8db0
|
21
|
|
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis, file e0feeaab-5696-44d2-e053-6605fe0a8db0
|
17
|
|
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells, file e0feeaa6-1010-44d2-e053-6605fe0a8db0
|
7
|
|
The corneal pocket assay, file e0feeaa4-d02e-44d2-e053-6605fe0a8db0
|
6
|
|
Role of prostaglandin E2 in EGFR mediated DU145 prostate cancer growth and epithelial mesenchymal transition, file e0feeaa8-45df-44d2-e053-6605fe0a8db0
|
6
|
|
The corneal pocket assay, file e0feeaa5-7606-44d2-e053-6605fe0a8db0
|
5
|
|
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite, file e0feeaa7-ef29-44d2-e053-6605fe0a8db0
|
5
|
|
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade, file 536be9d4-acff-4c3c-815a-c66ae9981fcd
|
4
|
|
Absence of PAF actions increases angiogenesis, file e0feeaa4-c612-44d2-e053-6605fe0a8db0
|
4
|
|
The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions, file e0feeaa4-f168-44d2-e053-6605fe0a8db0
|
4
|
|
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation, file e0feeaa9-f29e-44d2-e053-6605fe0a8db0
|
4
|
|
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2, file e0feeaa4-f15a-44d2-e053-6605fe0a8db0
|
3
|
|
PKCepsilon activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting., file e0feeaa4-fbc7-44d2-e053-6605fe0a8db0
|
3
|
|
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability, file e0feeaa5-2918-44d2-e053-6605fe0a8db0
|
3
|
|
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis, file e0feeaa9-2da4-44d2-e053-6605fe0a8db0
|
3
|
|
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivativederivative. Effect on the motility of vascular endothelial cells., file e0feeaa4-c6ff-44d2-e053-6605fe0a8db0
|
2
|
|
An angiogenic role for the neurotrophins midkine and pleiotrophin in tumorigenesis., file e0feeaa4-d794-44d2-e053-6605fe0a8db0
|
2
|
|
Nitric oxide in tumor angiogenesis., file e0feeaa4-d7a6-44d2-e053-6605fe0a8db0
|
2
|
|
A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A2 inhibitor, displays antitumour activity., file e0feeaa4-d7fc-44d2-e053-6605fe0a8db0
|
2
|
|
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety, file e0feeaa4-dae6-44d2-e053-6605fe0a8db0
|
2
|
|
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling, file e0feeaa4-dd3f-44d2-e053-6605fe0a8db0
|
2
|
|
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk., file e0feeaa4-e9d6-44d2-e053-6605fe0a8db0
|
2
|
|
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis., file e0feeaa4-fbc6-44d2-e053-6605fe0a8db0
|
2
|
|
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall, file e0feeaa5-f9e0-44d2-e053-6605fe0a8db0
|
2
|
|
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: A real-life setting study with gender prospective, file e0feeaaa-eac0-44d2-e053-6605fe0a8db0
|
2
|
|
Purine analogue 6-methylmercaptopurine ribose inhibits early and late phases of the angiogenic process., file e0feeaa4-c778-44d2-e053-6605fe0a8db0
|
1
|
|
The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability, file e0feeaa4-d66c-44d2-e053-6605fe0a8db0
|
1
|
|
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis, file e0feeaa4-d7fb-44d2-e053-6605fe0a8db0
|
1
|
|
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4, file e0feeaa4-db3a-44d2-e053-6605fe0a8db0
|
1
|
|
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof, file e0feeaa4-dbcd-44d2-e053-6605fe0a8db0
|
1
|
|
Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4, file e0feeaa4-dd22-44d2-e053-6605fe0a8db0
|
1
|
|
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium, file e0feeaa4-dfcd-44d2-e053-6605fe0a8db0
|
1
|
|
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis, file e0feeaa4-e0c3-44d2-e053-6605fe0a8db0
|
1
|
|
Nitric oxide and angiogenesis, file e0feeaa4-e23b-44d2-e053-6605fe0a8db0
|
1
|
|
Opposite effects of beta amyloid on endothelial cell survival: role of fibroblast growth factor-2 (FGF-2), file e0feeaa4-e3b7-44d2-e053-6605fe0a8db0
|
1
|
|
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress, file e0feeaa4-e644-44d2-e053-6605fe0a8db0
|
1
|
|
deltaPKC inhibition or epsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification, file e0feeaa4-e687-44d2-e053-6605fe0a8db0
|
1
|
|
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro, file e0feeaa4-ea35-44d2-e053-6605fe0a8db0
|
1
|
|
NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins, file e0feeaa4-edd0-44d2-e053-6605fe0a8db0
|
1
|
|
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2, file e0feeaa5-6e2d-44d2-e053-6605fe0a8db0
|
1
|
|
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis, file e0feeaa6-2d19-44d2-e053-6605fe0a8db0
|
1
|
|
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity, file e0feeaa7-2640-44d2-e053-6605fe0a8db0
|
1
|
|
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines, file e0feeaa8-115b-44d2-e053-6605fe0a8db0
|
1
|
|
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells, file e0feeaa9-cdd2-44d2-e053-6605fe0a8db0
|
1
|
|
Molecular mechanisms of resistance to anti-angiogenic drugs, file e0feeaaa-02f4-44d2-e053-6605fe0a8db0
|
1
|
|
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo, file e0feeaaa-38d6-44d2-e053-6605fe0a8db0
|
1
|
| Totale |
2.134 |